TR200001829T2 - Sedef hastalığı, sedef hastalığına dayalı eklem yangısı, deri yangıları ve bölgesel granülomatoz enteritin tedavisine yönelik olarak alkil hidrojen fumarat kullanımı - Google Patents

Sedef hastalığı, sedef hastalığına dayalı eklem yangısı, deri yangıları ve bölgesel granülomatoz enteritin tedavisine yönelik olarak alkil hidrojen fumarat kullanımı

Info

Publication number
TR200001829T2
TR200001829T2 TR2000/01829T TR200001829T TR200001829T2 TR 200001829 T2 TR200001829 T2 TR 200001829T2 TR 2000/01829 T TR2000/01829 T TR 2000/01829T TR 200001829 T TR200001829 T TR 200001829T TR 200001829 T2 TR200001829 T2 TR 200001829T2
Authority
TR
Turkey
Prior art keywords
psoriasis
treatment
fires
regional
skin
Prior art date
Application number
TR2000/01829T
Other languages
English (en)
Inventor
Rajendra Joshi K.
Strebel Hans-Peter
Original Assignee
Fumapharmag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fumapharmag filed Critical Fumapharmag
Publication of TR200001829T2 publication Critical patent/TR200001829T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Sedef hastaligi, sedef hastaligina dayali eklem yangisi, deri yangilari ve bölgesel granülomatoz enteritinin tedavisine yönelik olarak alkil hidrojen fumarat kullanimi. Duruma göre (II) förmülü dialkil fumarati ile ve duruma göre mutat farmasotik yardimci maddeler ve tasiyici maddelerle karma olarak psoriaksisin (sedef hastalilgi) psoriatik artritisin, Nörodermitisin ve enteritis ve regionalis crohn'un tedavisinde mikro tablet veya mikro-pelet seklinde farmasotik bir terkibin hazirlanmasi için, R'nin C1-5-Alkil oldogu genel formülün (L) bir ya da birkaç alkil hidrojen fumarati kullanimi.
TR2000/01829T 1998-03-31 1998-12-08 Sedef hastalığı, sedef hastalığına dayalı eklem yangısı, deri yangıları ve bölgesel granülomatoz enteritin tedavisine yönelik olarak alkil hidrojen fumarat kullanımı TR200001829T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19814358A DE19814358C2 (de) 1998-03-31 1998-03-31 Verwendung von Alkylhydrogenfumaraten zur Behandlung von Psoriasis, psoriatischer Arthritis, Neurodermitis und Enteritis regionalis Crohn

Publications (1)

Publication Number Publication Date
TR200001829T2 true TR200001829T2 (tr) 2000-11-21

Family

ID=7863089

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01829T TR200001829T2 (tr) 1998-03-31 1998-12-08 Sedef hastalığı, sedef hastalığına dayalı eklem yangısı, deri yangıları ve bölgesel granülomatoz enteritin tedavisine yönelik olarak alkil hidrojen fumarat kullanımı

Country Status (26)

Country Link
US (1) US6277882B1 (tr)
EP (1) EP1059920B1 (tr)
JP (1) JP3527890B2 (tr)
CN (1) CN1150898C (tr)
AT (1) ATE219936T1 (tr)
AU (1) AU745281B2 (tr)
BG (1) BG64744B1 (tr)
BR (1) BRPI9815772B8 (tr)
CA (1) CA2283915C (tr)
CZ (1) CZ291788B6 (tr)
DE (2) DE19814358C2 (tr)
DK (1) DK1059920T3 (tr)
EE (1) EE04702B1 (tr)
ES (1) ES2179551T3 (tr)
HK (1) HK1035134A1 (tr)
HU (1) HU228848B1 (tr)
IL (1) IL136835A (tr)
NO (1) NO327750B1 (tr)
NZ (1) NZ505341A (tr)
PL (1) PL191803B1 (tr)
PT (1) PT1059920E (tr)
RS (1) RS49658B (tr)
RU (1) RU2197233C2 (tr)
SK (1) SK285187B6 (tr)
TR (1) TR200001829T2 (tr)
WO (1) WO1999049858A1 (tr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19839566C2 (de) * 1998-08-31 2002-01-17 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
DE19853487A1 (de) * 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
DE10101307A1 (de) * 2001-01-12 2002-08-01 Fumapharm Ag Muri Fumarsäurederivate als NF-kappaB-Inhibitor
RS52083B (sr) * 2001-01-12 2012-06-30 Fumapharm Ag Amidi fumarne kiseline
DE10217314A1 (de) * 2002-04-18 2003-11-13 Fumapharm Ag Muri Carbocyclische und Oxacarboncyclische Fumarsäure-Oligomere
DE10360869A1 (de) * 2003-09-09 2005-04-07 Fumapharm Ag Verwendung von Fumarsäurederivaten zur Therapie der Herzinsuffizienz, der Hyperkeratose und von Asthma
EP1663197B1 (en) * 2003-09-09 2007-12-05 Fumapharm AG The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
LT2801354T (lt) 2004-10-08 2017-06-26 Forward Pharma A/S Kontroliuojamo atpalaidavimo farmacinės kompozicijos, apimančios fumaro rūgšties esterį
US20080004344A1 (en) * 2004-11-10 2008-01-03 Aditech Pharma Ab Novel Salts of Fumaric Acid Monoalkylesters and Their Pharmaceutical Use
EP2186819A1 (en) 2005-07-07 2010-05-19 Aditech Pharma AG Novel glucopyranose esters and glucofuranose esters of alkyl- fumarates and their pharmaceutical use
WO2007006307A2 (en) * 2005-07-07 2007-01-18 Aditech Pharma Ab Novel salts of fumaric acid monoalkylesters and their pharmaceutical use
JP2009510137A (ja) * 2005-10-07 2009-03-12 アディテック・ファルマ・アクチボラゲット フマル酸エステルを含む制御放出医薬組成物
WO2007042035A2 (en) * 2005-10-07 2007-04-19 Aditech Pharma Ab Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders
HRP20220902T3 (hr) 2007-02-08 2022-10-14 Biogen Ma Inc. Pripravci i njihova upotreba u liječenju multiple skleroze
HUE032251T2 (en) * 2007-02-08 2017-09-28 Biogen Ma Inc Neuroprotection in demyelinating diseases
MX2011001341A (es) 2008-08-19 2011-03-29 Xenoport Inc Prodrogas de metil hidrogeno fumarato, sus composiciones farmaceuticas, y metodos de uso.
US8906420B2 (en) 2009-01-09 2014-12-09 Forward Pharma A/S Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
US9422226B2 (en) 2011-06-08 2016-08-23 Biogen Ma Inc. Process for preparing high purity and crystalline dimethyl fumarate
RU2014125430A (ru) 2011-11-24 2015-12-27 Синтон Бв Контролируемое высвобождение частиц, содержащих диметилфумарат
US20130158077A1 (en) 2011-12-19 2013-06-20 Ares Trading S.A. Pharmaceutical compositions
US9504679B2 (en) 2011-12-19 2016-11-29 Bjoern Colin Kahrs Pharmaceutical compositions comprising glitazones and Nrf2 activators
JP5918395B2 (ja) 2012-02-07 2016-05-18 ゼノポート，インコーポレイティド モルホリノアルキルフマレート化合物、医薬組成物及び使用方法
CN104220061A (zh) * 2012-02-07 2014-12-17 比奥根艾迪克依蒙菲利亚公司 含有富马酸二甲酯的药物组合物
KR101449114B1 (ko) * 2012-08-21 2014-10-13 바이오스펙트럼 주식회사 푸마르산을 유효성분으로 포함하는 항염 조성물
US10945984B2 (en) 2012-08-22 2021-03-16 Arbor Pharmaceuticals, Llc Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
JP2015526476A (ja) * 2012-08-22 2015-09-10 ゼノポート，インコーポレイティド メチル水素フマレートの経口剤形およびそのプロドラッグ
US20140171504A1 (en) 2012-12-14 2014-06-19 Georgia Regents Research Institute, Inc. Methods of Treating Sickle Cell Disease and Related Disorders Using Fumaric Acid Esters
AR094277A1 (es) 2012-12-21 2015-07-22 Biogen Idec Inc Derivados de fumarato sustituidos con deuterio
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
PT2970101T (pt) 2013-03-14 2018-10-04 Alkermes Pharma Ireland Ltd Pró-fármacos de fumaratos e seu uso no tratamento de várias doenças
US10179118B2 (en) 2013-03-24 2019-01-15 Arbor Pharmaceuticals, Llc Pharmaceutical compositions of dimethyl fumarate
WO2014197860A1 (en) 2013-06-07 2014-12-11 Xenoport, Inc. Method of making monomethyl fumarate
US9421182B2 (en) 2013-06-21 2016-08-23 Xenoport, Inc. Cocrystals of dimethyl fumarate
JP2016528302A (ja) 2013-08-26 2016-09-15 フォーワード・ファルマ・アクティーゼルスカブＦｏｒｗａｒｄ Ｐｈａｒｍａ Ａ／Ｓ 低１日用量で投与するためのフマル酸ジメチルを含む医薬組成物
JP2016534133A (ja) 2013-09-06 2016-11-04 ゼノポート，インコーポレイティド （ｎ，ｎ−ジエチルカルバモイル）メチル メチル（２ｅ）ブト−２−エン−１，４−ジオエートの結晶形態、その合成方法及び使用
WO2015042294A1 (en) 2013-09-18 2015-03-26 Xenoport, Inc. Nanoparticle compositions of dimethyl fumarate
NZ723269A (en) 2014-02-24 2017-04-28 Alkermes Pharma Ireland Ltd Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
WO2016040860A1 (en) * 2014-09-12 2016-03-17 Tobira Therapeutics, Inc. Cenicriviroc combination therapy for the treatment of fibrosis
WO2016061393A1 (en) 2014-10-15 2016-04-21 Xenoport, Inc. Fumarate compounds, pharmaceutical compositions, and methods of use
HRP20211269T1 (hr) 2015-02-08 2022-01-21 Alkermes Pharma Ireland Limited Kompozicije prolijeka na bazi monometil fumarata
DK3273951T3 (da) 2015-03-27 2020-11-02 Symbionyx Pharmaceuticals Inc Sammensætninger og fremgangsmåder til behandling af psoriasis
WO2017060400A1 (en) 2015-10-07 2017-04-13 Neurovive Pharmaceutical Ab Protected carboxylic acid-based metabolites for the treatment of disesases related to mitochondrial dysfunctions
CN105496804A (zh) * 2015-12-25 2016-04-20 知识产权全资有限公司 用于处理头发以及治疗头部牛皮藓的配方及其试剂盒和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2530372A1 (de) * 1975-07-08 1977-01-13 Walter Dr Schweckendiek Pharmazeutische zubereitungen zur behandlung von psoriasis
DE2621214C3 (de) * 1976-05-13 1981-11-12 Koronis Gmbh Chemisch-Pharmazeutische Praeparate, 5441 Sassen Verwendung von Stabilisatoren in Arzneimitteln mit Fumarsäuremonoäthylester und desen Mineralsalzen
DE3127432A1 (de) * 1981-07-11 1983-02-03 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von fumarsaeuremonoester
US5242905A (en) * 1987-09-04 1993-09-07 Dexter Chemical Corporation Pharmaceutical compositions for the treatment of psoriasis
US5214196A (en) * 1987-09-04 1993-05-25 Dexter Chemical Corporation Diethyl ester of di-glycyl fumaramide
US4959389A (en) * 1987-10-19 1990-09-25 Speiser Peter P Pharmaceutical preparation for the treatment of psoriatic arthritis
US5424332A (en) * 1987-10-19 1995-06-13 Speiser; Peter P. Pharmaceutical composition and process for the production thereof
DE8714143U1 (tr) * 1987-10-23 1988-03-24 Werler Kunststoffwerke Gmbh & Co, 4760 Werl, De
DE3834794A1 (de) 1988-10-12 1990-04-19 F Schielein Oral zu verabreichendes mittel zur behandlung von psoriasis
AU1271592A (en) * 1991-01-18 1992-08-27 Dexter Chemical Corporation Malic acid derivatives and compositions for the treatment of psoriasis
US5407772A (en) * 1993-11-30 1995-04-18 Xerox Corporation Unsaturated polyesters
US5972363A (en) * 1997-04-11 1999-10-26 Rohm And Haas Company Use of an encapsulated bioactive composition

Also Published As

Publication number Publication date
BRPI9815772B8 (pt) 2021-07-06
NZ505341A (en) 2002-04-26
PL341240A1 (en) 2001-03-26
ES2179551T3 (es) 2003-01-16
DE59804704D1 (de) 2002-08-08
AU745281B2 (en) 2002-03-21
ATE219936T1 (de) 2002-07-15
AU2159399A (en) 1999-10-18
BG104566A (en) 2001-01-31
HUP0103234A3 (en) 2003-11-28
CZ20003086A3 (cs) 2000-11-15
DE19814358C2 (de) 2002-01-17
YU32000A (sh) 2002-03-18
PT1059920E (pt) 2002-11-29
HUP0103234A2 (hu) 2002-01-28
CZ291788B6 (cs) 2003-05-14
BRPI9815772B1 (pt) 2016-02-10
JP3527890B2 (ja) 2004-05-17
HU228848B1 (en) 2013-06-28
IL136835A0 (en) 2001-06-14
HK1035134A1 (en) 2001-11-16
PL191803B1 (pl) 2006-07-31
NO327750B1 (no) 2009-09-14
SK7922000A3 (en) 2001-01-18
EP1059920A1 (de) 2000-12-20
BG64744B1 (bg) 2006-02-28
CN1284870A (zh) 2001-02-21
EP1059920B1 (de) 2002-07-03
BRPI9815772A (pt) 2000-11-21
SK285187B6 (sk) 2006-08-03
WO1999049858A1 (de) 1999-10-07
NO20002872L (no) 2000-06-06
DK1059920T3 (da) 2002-10-14
CA2283915C (en) 2002-12-03
RS49658B (sr) 2007-09-21
US6277882B1 (en) 2001-08-21
CA2283915A1 (en) 1999-09-30
IL136835A (en) 2005-05-17
RU2197233C2 (ru) 2003-01-27
NO20002872D0 (no) 2000-06-06
DE19814358A1 (de) 1999-10-07
EE04702B1 (et) 2006-10-16
CN1150898C (zh) 2004-05-26
EE200000440A (et) 2001-12-17
JP2002509883A (ja) 2002-04-02

Similar Documents

Publication Publication Date Title
TR200001829T2 (tr) Sedef hastalığı, sedef hastalığına dayalı eklem yangısı, deri yangıları ve bölgesel granülomatoz enteritin tedavisine yönelik olarak alkil hidrojen fumarat kullanımı
OA09850A (fr) Conjugués d'interféron et composés les contenant.
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
DE69309487T2 (de) Peripheralisierung hämatopoietischer stammzellen
DK1075260T3 (da) Hidtil ukendte fedtsyreanaloger til behandling af sekundær restenose
TR199801195T2 (tr) Tedavide yararli kinolin ve kinozilin bilesikleri.
BG103656A (en) Fluoroether compositions and methods for their decomposition inhibition in the presence of lewis acid
DE69736515D1 (de) Neue ortho-naphthochinonderivate, neue synthesen zu ihrer herstellung und ihre anwendung in der inhibierung von neoplastischem zellwachstum
GR1002351B (el) Αντιφλεγμονωδεις συνθεσεις που περιεχουν πιροξικαμ (piroxicam).
NZ333281A (en) Asymmetric stilbene compounds for use as sun protection agents
TR199900644T2 (tr) 1,2,3,4-Tetrahidro-benzofuro [3,2-c] piridin türevleri.
MX9804451A (es) Composiciones de proteccion solar, estabilizadas.
ES2133833T3 (es) Diaminoalquil di(sulfosuccinatos) y composiciones detergentes que los contienen.
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
TR200401462T4 (tr) Torsemid modifikasyonu II' yi içeren dengeli bir farmasötik formülasyonu
TR200001715T2 (tr) Potasyum kanalı açıcıları.
TR200100953T2 (tr) Farmasötikler olarak üç halkalı delta3-piperidinler
HU9601498D0 (en) Use of dimeticone for treating constipation
NZ326769A (en) High-content famciclovir tablets
EP0654269A4 (en) MEDICAL COMPOSITION FOR INHIBITING CANCER METASAS IN LIVER AND MEDICAL COMPOSITION FOR TREATING THE HEPATOMA.
IT8520148A0 (it) Procedimento e mezzi da utilizzare nell'installazione di generatori di plasma in forni a tino.
JPS53102912A (en) Toilet soap composition
BE903651A (fr) Alpha - (((2 - hydroxy -1,1- dimethyl - ethyl) amino) methyl), benzene methanol et ses sels, leurs procedes de preparation et leur utilisation.
Holliday et al. Lighting design: feature
MY106292A (en) (alpha)-adrenergic receptor antagonists.